Eli Lilly CEO David Ricks on the end of antibody study in hospitalized patients

U.S. government officials have put an early end to a study testing an Eli Lilly antibody drug for people hospitalized with Covid-19 because it doesn't seem to be helping them. Eli Lilly CEO David Ricks joins "Squawk Box" to discuss the study and what's next for the company in researching solutions for coronavirus.
03:24
Tue, Oct 27 20209:07 AM EDT